Evaluation of antibody drug delivery efficiency via nebulizer in various airway models and breathing patterns

BACKGROUND: Nebulizers are commonly used to treat respiratory diseases, which are a major cause of morbidity and mortality. While inhalation therapy with antibodies has been evaluated in preclinical studies and clinical trials for respiratory diseases, it has not yet been approved for treatment. Mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Soon Woo, Chang, Kyung Hwa, Woo, Chang Jae, Kim, Ho Chul, Kwak, Bong Seop, Park, Bong Joo, Nam, Ki Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691028/
https://www.ncbi.nlm.nih.gov/pubmed/38041207
http://dx.doi.org/10.1186/s40360-023-00711-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691028/
https://www.ncbi.nlm.nih.gov/pubmed/38041207
http://dx.doi.org/10.1186/s40360-023-00711-9

Ejemplares similares